Interesting that PNV update comments on Europe will bode well for MVP too.
Europe is back to normal so the sales team have a clear runway and face to face sales opportunities is great news, can't wait for the AGM sales update and if management can drop an update pre the AGM it would be good to see.
COVID Trading ThemesUK, Ireland and EU open for businessThe EU is open for business and appears to be living with Covid. Face to face meetings are back, conferences are being attended and hospital access has returned to near normal levels. We expect to sign additional distributors in Q2, including Cyprus and the Czech Republic. Other jurisdictions such as France and Portugal are in negotiation. The EU performed well up 204% in Q1 FY22 over Q1 FY21.A new 3PL distribution centre in Belgium is operational and filling sales orders with deliveries to Germany, Finland, and an order from Italy being filled this week. All indications are that orders will commence soon to other distributors in Poland, Turkey, and Greece.The relaxation of Covid restrictions in UK and Irish hospitals has been positive for the business, also buoyed by some clinical trials. Q1 FY22 sales were up 327% on same quarter last year.
MVP Price at posting:
$5.02 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)